Client: Abbott Virology In 2010, US Treatment Guidelines identified lopinavir/ritonavir as the preferred protease inhibitor for the treatment of … MORE
Featured Work
Rebranding an industry association
Client: Generic Industry Medicines Association (GMiA) The generic medicines industry is undergoing significant change. The introduction of a new category … MORE
PAH Clinic
Client: Janssen Australia Janssen is a global leader in the science and medicine of Pulmonary Arterial Hypertension having launched the first … MORE
Launching a new treatment for Dupuytren’s contracture
Client: Janssen Australia Leo Creative worked with Janssen on the Australian launch of collagenase – a non-surgical TGA approved treatment for Dupuytren’s … MORE
PAH Clinic: Speaker Tour Issue
Client: Janssen Australia When Janssen Australia sponsored a world-renowned Pulmonary Arterial Hypertension (PAH) expert to visit Australia, Leo Creative was … MORE
A new direction in the treatment of Peyronie’s disease
Client: Janssen Australia When Janssen was granted a second indication for collagenase clostridium histolyticum by the Therapeutic Goods Administration – for … MORE
Patient and physician demonstration kits
Client: Janssen Australia A common barrier to treatment with some drugs can be administration. This is certainly the case for Janssen’s treatment for … MORE
Rebranding Australian Self Medication Industry (ASMI)
Client: CHPA Leo Creative was engaged by the Australian Self Medication Industry (ASMI) to help them rebrand in 2019. ASMI was the industry association … MORE
Brand Identity: more than a logo
Client: NEXUS APAC Group Many people mistakenly believe that a brand is just a logo, but that couldn’t be further from the truth. Even if we do just … MORE